Call Us
+1(647) 892-3036Mail Us
info@nanoinhaler.caFrequently Asked Questions
NanoIn is a respiratory health technology concept focused on smart inhaler use, AI-supported monitoring, environmental awareness, and better communication between patients and healthcare providers.
The NanoInhaler is presented as a smart respiratory device concept designed to support more accurate inhaler use, medication tracking, and connected respiratory monitoring.
NanoIn is currently presented through a website, product page, and live demo environment. The physical medical device, regulatory review, manufacturing process, and full clinical validation require further development, testing, funding, and compliance work.
The Live Demo shows how the future NanoIn platform may work for two types of users: patients and physicians. It includes dashboards, risk indicators, adherence tracking, environmental information, alerts, and communication tools.
Patients can see information such as inhaler usage, remaining dose, adherence status, air quality, risk level, appointments, reports, recent activity, and doctor communication.
Physicians can review patient status, risk levels, adherence data, alerts, patient queues, trend charts, map-based risk zones, device information, and patient communication.
No. NanoIn is not intended to replace professional medical advice, diagnosis, or treatment. Patients should always follow the guidance of qualified healthcare professionals.
NanoIn is mainly focused on asthma and COPD-related respiratory care, especially where inhaler technique, adherence, environmental triggers, and early risk awareness are important.
Environmental risk intelligence refers to using information such as air quality, pollen, humidity, smoke, and weather conditions to help identify possible respiratory triggers.
Predictive risk monitoring means using data patterns to estimate whether a patient may be at higher risk of respiratory symptoms or an attack in the near future.
NanoIn is designed for patients, caregivers, physicians, clinics, and healthcare organizations interested in connected respiratory monitoring and smarter inhaler use.
Visitors can contact NanoIn through the Contact page, by email at info@nanoinhaler.ca, or by phone at +1 (647) 892-3036. The website also provides the business address and a contact form for direct messages.